Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer [Phase 2]
This clinical trial update reports a Phase 2 study of alpelisib combined with fulvestrant for endometrial cancer. The trial is currently act…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer [Phase 3]
A Phase 3 clinical trial evaluating Rina-S versus investigator's choice therapy in endometrial cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder [Phase 2]
Phase 2 clinical trial evaluating psilocybin-assisted psychotherapy for adjustment disorder in cancer patients; recruitment is ongoing acros…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
A clinical trial update describes a study of durvalumab with or without olaparib in endometrial cancer patients under post-marketing surveil…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome [NA]
A clinical trial is evaluating a menstrual cup as a noninvasive method for early detection of endometrial cancer in women with Lynch syndrom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors [Phase 1, Phase 2]
AZD5335 is being studied in Phase 1/2a as both a single-agent therapy and in combination therapy for solid tumors, with recruitment ongoing.…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Karyopharm Expanded Access Program for Selinexor
This update covers Karyopharm's Expanded Access Program for selinexor (Xpovio), including eligibility and current availability for listed ca…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
This clinical trial update notes ongoing recruitment for a study evaluating late radiation toxicities after postoperative IMRT and brachythe…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial [Phase 2]
Phase 2 trial update on progestins for treating endometrial cancer or precancers before surgery; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: PRO1107 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 PRO1107 trial in advanced solid tumors, including endometrial and ovarian cancers, has been terminated.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer
This clinical trial update describes the development of a shared decision tool to facilitate uptake of the levonorgestrel-releasing intraute…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Navigation Intervention for Adolescent and Young Adult Cancer Survivors [NA]
A Kaiser Permanente-sponsored clinical trial update describes a navigation intervention for adolescent and young adult cancer survivors. The…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma [Phase 1]
A Phase 1 clinical trial is evaluating the combination of lenvatinib and pembrolizumab with hypofractionated pelvic radiation therapy for pa…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation
An observational study conducted by AstraZeneca in Russia examines molecular profiling of advanced and aggressive endometrial cancer and fir…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding
Clinical trial evaluating DNA methylation markers for endometrial cancer risk stratification using patient-collected urine and vaginal sampl…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers [Phase 1]
The first-in-human Phase 1 study of ATX-559, an oral DHX9 inhibitor from Accent Therapeutics, has been terminated; the trial included patien…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: An Exploratory Study of Detection of Endometrial and Ovarian Cancers in Vaginal Samples Retrieved by the Ellele Sampling Device [NA]
An exploratory study aims to detect endometrial and ovarian cancers in vaginal samples collected with the Ellele Sampling Device; the trial …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: First in Human Study of IMGN151 in Recurrent Gynaecological Cancers [Phase 1]
This update covers the first-in-human Phase 1 study of IMGN151 in recurrent gynecologic cancers, sponsored by AbbVie, with the trial status …
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Individual Approach in Gynecological Cancer Brachytherapy [NA]
This completed clinical trial investigated an individualized brachytherapy approach for gynecologic cancers, aiming to optimize radiation de…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Onco-primary Care Networking to Support TEAM-based Care [NA]
Clinical trial update noting that the Duke University study on oncology-primary care networking to support TEAM-based care is currently ACTI…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors [EARLY_Phase 1]
Early-phase clinical trial investigating a radiolabeled anti-PD-L1 single-domain antibody (177Lu-anti-PD-L1 sdAb) in metastatic solid tumors…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
This is a prospective, multicenter, single-arm observational study evaluating outcomes of low-risk endometrial cancer with isolated tumor ce…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy [NA]
A Dana-Farber Cancer Institute trial is exploring whether structured exercise can prevent immobility in patients with ovarian or endometrial…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)
A non-interventional study (NIS) evaluating the effectiveness and safety of durvalumab and olaparib in patients with endometrial cancer (DUO…